Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex Vivo LRRK2 Activation in Asian G2385R and R1628P Variant Carriers and Idiopathic Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

The <i>LRRK2</i> p.A419V variant associates with risk of Parkinson's disease in the East Asian population and an evaluation on age of onset.

medRxiv : the preprint server for health sciences·2025
Same author

<i>Candida auris</i> adhesins, specifically Als3, a key target to understand and mitigate.

Mycologia·2025
Same author

Selective Stabilization of LRRK2 Kinase Conformations Reveals Distinct Modes of Action for Type I and II Inhibitors.

Cell biochemistry and biophysics·2025
Same author

Exploring the Impact of LRRK2 WD40 G2294R Mutation on Conformation and Dimerisation Dynamics: Insights From Molecular Dynamics Simulation.

Journal of cellular biochemistry·2025
Same author

Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant.

NPJ Parkinson's disease·2025

Related Experiment Video

Updated: Jun 16, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.7K

Comparative Molecular Dynamics Reveals How LRRK2 Inhibitors Distinguish G2019S from Wild-Type.

Chuancheng Wei1, Choon Han Heh1, Lei Cheng Lit2

  • 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.

Neurochemical Research
|August 13, 2025
PubMed
Summary
This summary is machine-generated.

Molecular dynamics simulations reveal how inhibitors selectively target Leucine-rich repeat kinase 2 (LRRK2) mutations in Parkinson's disease. Ligand binding induces conformational changes, destabilizing the kinase for targeted therapy.

Keywords:
Conformational changesG2019S/WT selectivityKinase-Ligand interactionLRRK2 inhibitorsMolecular dynamics

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.1K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.4K

Related Experiment Videos

Last Updated: Jun 16, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.7K
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.1K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.4K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Biology

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is a key drug target for Parkinson's disease.
  • Developing mutation-selective inhibitors is crucial for precision medicine approaches.
  • Structural similarities between mutant and wild-type LRRK2 pose challenges for inhibitor selectivity.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the selectivity of LRRK2 inhibitors.
  • To explore kinase-ligand interactions and their role in achieving selectivity.
  • To identify key factors influencing the selective inhibition of LRRK2 mutants.

Main Methods:

  • Molecular dynamics (MD) simulations were employed to analyze kinase-ligand interactions.
  • Conformational changes induced by ligand binding were examined.
  • The role of specific amino acid residues in selectivity was investigated.

Main Results:

  • Ligand binding, rather than binding strength, was identified as the primary driver of selectivity.
  • Ligand-induced conformational changes lead to kinase destabilization and inactivation.
  • Key residues, including Tyr2018 and Asp2017, were found to be critical for inhibitor selectivity.

Conclusions:

  • Conformational dynamics are essential for understanding and achieving LRRK2 mutant selectivity.
  • These findings provide critical insights for the rational design of next-generation LRRK2 inhibitors.
  • Targeting conformational changes offers a promising strategy for Parkinson's disease precision medicine.